These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25886513)

  • 1. Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey.
    Akinyemiju TF; McDonald JA; Lantz PM
    BMC Public Health; 2015 Apr; 15():382. PubMed ID: 25886513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities.
    Horner-Johnson W; Dobbertin K; Iezzoni LI
    Womens Health Issues; 2015; 25(3):246-53. PubMed ID: 25864023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model.
    Lott BE; Trejo MJ; Baum C; McClelland DJ; Adsul P; Madhivanan P; Carvajal S; Ernst K; Ehiri J
    BMC Public Health; 2020 May; 20(1):654. PubMed ID: 32393218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between multiple dimensions of access to care and cervical cancer screening among Kenyan women: a cross-sectional analysis of the Demographic Health Survey.
    Li X; Chen S; Hirose N; Shimpuku Y
    BMC Health Serv Res; 2024 Jun; 24(1):731. PubMed ID: 38877555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's Cancer Care in Iran.
    Joulaei H; Zarei N
    Cancer Control; 2019; 26(1):1073274819848432. PubMed ID: 31094222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
    Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
    BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
    AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review.
    Lim JN; Ojo AA
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26853214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast and cervical cancer screening and associated factors among older adult women in South Africa.
    Peltzer K; Phaswana-Mafuya N
    Asian Pac J Cancer Prev; 2014; 15(6):2473-6. PubMed ID: 24761849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis.
    Ahmad F; Stewart DE; Cameron JI; Hyman I
    J Womens Health Gend Based Med; 2001 Mar; 10(2):201-8. PubMed ID: 11268303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
    Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
    Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.